680Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome?

Laurent Fauchier; Arnaud Bisson; Alexandre Bodin; Nicolas Clémenty; Clémentine André; Bertrand Pierre; D Babuty; Professor Gregory Lip

doi:10.1093/europace/euy015.325

Back

680Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome?

Article 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2012

Acute Coronary Syndrome in Patients With Atrial Fibrillation

Aldo Maggioni

Article2020

Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting

Monika Kozieł, Tatjana Potpara, Professor Gregory Lip

Article2020

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention

M Mihajlović, M Marinković, Monika Kozieł, Nebojša Mujović, Professor Gregory Lip, Tatjana Potpara

Article2016

Prognosis in patients with atrial fibrillation and a presumed “temporary cause” in a community-based cohort study

Laurent Fauchier, Nicolas Clémenty, Arnaud Bisson, Karim Stamboul, Fabrice Ivanés, Denis Angoulvant, Dominique Babuty, Professor Gregory Lip

Article2022

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease

So-Ryoung Lee, Jin‐Hyung Jung, Eue-Keun Choi, Seung‐Woo Lee, Soonil Kwon, Ji-Suck Park, Jeehoon Kang, Kyungdo Han, Kyung Woo Park, Seil Oh, Professor Gregory Lip